Pandora Wealth’s Definium Therapeutics DFTX Stock Holding History

Pandora Wealth’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-131	Closed	-$850	–	264
2025 Q2	$850	Hold	131	–	–	﹤0.01%	268
2025 Q1	$766	Buy	+131	New	+$938	﹤0.01%	241

Other funds holding DFTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Pandora Wealth's DFTX Position: Q3 2025 in Review

Pandora Wealth sold out of Definium Therapeutics (DFTX) in Q3 2025, closing a stake of 131 shares — an estimated $850 sold.

Pandora Wealth first reported a position in DFTX in Q1 2025 and held it in 2 quarters. The position peaked at $850 in Q2 2025. 195 funds tracked by Wall St. Rank hold DFTX as of Q3 2025.

Pandora Wealth reported no remaining Definium Therapeutics position as of Q3 2025 after selling out during the quarter.
Pandora Wealth sold 131 Definium Therapeutics shares in Q3 2025, an estimated $850.
Pandora Wealth first reported a position in Definium Therapeutics in Q1 2025 and held it in 2 quarters.
Pandora Wealth's Definium Therapeutics position peaked at $850 in Q2 2025.
195 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2025.

Based on Pandora Wealth's 13F filing for Q3 2025, filed 3 Nov 2025.